Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Bahr

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Molecular Cancer|February 2, 2023
Immunotherapies in rare cancersSneha Vivekanandhan, Deborah Bahr, Ashish Kothari, et al.
Research Square|April 22, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanomaEmmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Scientific Reports|October 19, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanomaEmmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
ACS Biomaterials Science & Engineering|April 13, 2024
Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of MelanomaEmmanuel M Gabriel, Deborah Bahr, Hari Krishnareddy Rachamala, et al.
Cancer Research|October 11, 2017
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian CancerPurushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Molecular Cancer|February 2, 2023
Immunotherapies in rare cancersSneha Vivekanandhan, Deborah Bahr, Ashish Kothari, et al.
Research Square|April 22, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanomaEmmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Scientific Reports|October 19, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanomaEmmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
ACS Biomaterials Science & Engineering|April 13, 2024
Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of MelanomaEmmanuel M Gabriel, Deborah Bahr, Hari Krishnareddy Rachamala, et al.
Cancer Research|October 11, 2017
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian CancerPurushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, et al.
Pageof 1